Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection

Stroke

Volumn 46, Issue 7, 2015, Pages 1947-1955

  Sun, Yu Yo ^a   Li, Yikun ^a   Wali, Bushra ^b   Li, Yuancheng ^b   Lee, Jolly ^a   Heinmiller, Andrew ^c   Abe, Koji ^d   Stein, Donald G ^b   Mao, Hui ^b   Sayeed, Iqbal ^b   Kuan, Chia Yi ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Visualsonics Inc   (Canada)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

antioxidants; MCI 186; stroke; thrombosis

Indexed keywords

NORPHENAZONE; SODIUM CHLORIDE; NEUROPROTECTIVE AGENT; PHENAZONE; PHENYLMETHYLPYRAZOLONE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN METABOLISM; C57BL 6 MOUSE; COGNITIVE DEFECT; COMMON CAROTID ARTERY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMAGING AND DISPLAY; INVESTIGATIVE PROCEDURES; JAPAN; LASER SPECKLE CONTRAST IMAGING; LEARNING DISORDER; MALE; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; OXYGEN SATURATION; PERIOPERATIVE PERIOD; PHOTOACOUSTICS; PRIORITY JOURNAL; REPERFUSION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; HYPOXIA-ISCHEMIA, BRAIN; METABOLISM; PATHOLOGY; PROCEDURES; RANDOMIZATION;

ANIMALS; ANTIPYRINE; FREE RADICAL SCAVENGERS; HYPOXIA-ISCHEMIA, BRAIN; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; PERIOPERATIVE CARE; RANDOM ALLOCATION;

EID: 84942924559     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009162     Document Type: Article

References (32)

1. Selim M. Perioperative stroke. N Engl J Med. 2007;356:706-713. doi:10.1056/NEJMra062668.
2. Likosky DS, Caplan LR, Weintraub RM, Hartman GS, Malenka DJ, Ross CS, et al; Northern New England Cardiovascular Disease Study Group, Lebanon, New Hampshire. Intraoperative and postoperative variables associated with strokes following cardiac surgery. Heart Surg Forum. 2004;7:E271-E276. doi: 10.1532/HSF98.20041035.
3. Gerraty RP, Gates PC, Doyle JC. Carotid stenosis and perioperative stroke risk in symptomatic and asymptomatic patients undergoing vascular or coronary surgery. Stroke. 1993;24:1115-1118.
4. Naylor AR, Mehta Z, Rothwell PM, Bell PR. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg. 2002;23:283-294. doi: 10.1053/ejvs.2002.1609.
5. Nah HW, Lee JW, Chung CH, Choo SJ, Kwon SU, Kim JS, et al. New brain infarcts on magnetic resonance imaging after coronary artery bypass graft surgery: lesion patterns, mechanism, and predictors. Ann Neurol. 2014;76:347-355. doi: 10.1002/ana.24238.
6. Selnes OA, McKhann GM. Neurocognitive complications after coronary artery bypass surgery. Ann Neurol. 2005;57:615-621. doi: 10.1002/ana.20481.
7. Tang YH, Vital S, Russell J, Seifert H, Senchenkova E, Granger DN. Transient ischemia elicits a sustained enhancement of thrombus development in the cerebral microvasculature: effects of anti-thrombotic therapy. Exp Neurol. 2014;261:417-423. doi: 10.1016/j.expneurol.2014.07.004.
8. Adhami F, Liao G, Morozov YM, Schloemer A, Schmithorst VJ, Lorenz JN, et al. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol. 2006;169:566-583. doi: 10.2353/ajpath.2006.051066.
9. Sun YY, Morozov YM, Yang D, Li Y, Dunn RS, Rakic P, et al. Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke. PLoS One. 2014;9:e98807. doi: 10.1371/journal.pone.0098807.
10. van Hinsbergh VW. Endothelium-role in regulation of coagulation and inflammation. Semin Immunopathol. 2012;34:93-106. doi: 10.1007/s00281-011-0285-5.
11. Jackson SP. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med. 2011;17:1423-1436. doi: 10.1038/nm.2515.
12. Bilotta F, Gelb AW, Stazi E, Titi L, Paoloni FP, Rosa G. Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials. Br J Anaesth. 2013;110 Suppl 1:1113-1120. doi: 10.1093/bja/aet059.
13. Watanabe T, Tahara M, Todo S. The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther. 2008;26:101-114. doi: 10.1111/j.1527-3466.2008.00041.x.
14. Lapchak PA. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin Pharmacother. 2010;11:1753-1763. doi: 10.1517/14656566.2010.493558.
15. Edaravone Acute Infarction Study Group Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovascular diseases 2003;15:222-229.
16. Kaste M, Murayama S, Ford GA, Dippel DW, Walters MR, Tatlisumak T; MCI-186 study group. Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen. Cerebrovasc Dis. 2013;36:196-204. doi:10.1159/000353680.
17. Kimura K, Aoki J, Sakamoto Y, Kobayashi K, Sakai K, Inoue T, et al. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients-a preliminary study. J Neurol Sci. 2012;313:132-136. doi: 10.1016/j. jns.2011.09.006.
18. Higashi Y. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress. Expert Opin Pharmacother. 2009;10:323-331. doi: 10.1517/14656560802636888.
19. Watanabe T, Morita I, Nishi H, Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot Essent Fatty Acids. 1988;33:81-87.
20. Lee BJ, Egi Y, van Leyen K, Lo EH, Arai K. Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro. Brain Res. 2010;1307:22-27. doi: 10.1016/j. brainres.2009.10.026.
21. Deguchi K, Liu N, Liu W, Omote Y, Kono S, Yunoki T, et al. Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia. J Neurosci Res. 2014;92:1509-1519. doi: 10.1002/jnr.23420.
22. Needles A, Heinmiller A, Sun J, Theodoropoulos C, Bates D, Hirson D, et al. Development and initial application of a fully integrated photoacoustic micro-ultrasound system. IEEE Trans Ultrason Ferroelectr Freq Control. 2013;60:888-897. doi: 10.1109/TUFFC.2013.2646.
23. Mao H, Toufexis D, Wang X, Lacreuse A, Wu S. Changes of metabolite profile in kainic acid induced hippocampal injury in rats measured by HRMAS NMR. Exp Brain Res. 2007;183:477-485. doi: 10.1007/s00221-007-1061-6.
24. Wali B, Ishrat T, Won S, Stein DG, Sayeed I. Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study. Brain. 2014;137(Pt 2):486-502. doi: 10.1093/brain/awt319.
25. Chouchani ET, Pell VR, Gaude E, Aksentijevi? D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431-435. doi: 10.1038/nature13909.
26. Gyngell ML, Busch E, Schmitz B, Kohno K, Back T, Hoehn-Berlage M, et al. Evolution of acute focal cerebral ischaemia in rats observed by localized 1H MRS, diffusion-weighted MRI, and electrophysiological monitoring. NMR Biomed. 1995;8:206-214.
27. Arrowsmith JE, Harrison MJ, Newman SP, Stygall J, Timberlake N, Pugsley WB. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke. 1998;29:2357-2362.
28. Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, et al; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980-989. doi: 10.1056/NEJMoa0808207.
29. Mathew JP, White WD, Schinderle DB, Podgoreanu MV, Berger M, Milano CA, et al; Neurologic Outcome Research Group (NORG) of The Duke Heart Center. Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke. 2013;44:3407-3413. doi: 10.1161/STROKEAHA.113.002703.
30. Terrando N, Eriksson LI, Ryu JK, Yang T, Monaco C, Feldmann M, et al. Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol. 2011;70:986-995. doi: 10.1002/ana.22664.
31. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med. 1999;340:1555-1564. doi: 10.1056/NEJM199905203402007.
32. Zhang W, Sato K, Hayashi T, Omori N, Nagano I, Kato S, et al. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol Res. 2004;26:342-348. doi: 10.1179/016164104225014058.